Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 17;13(6):e70431.
doi: 10.1002/fsn3.70431. eCollection 2025 Jun.

Vitamin K: Metabolism, Genetic Influences, and Chronic Disease Outcomes

Affiliations
Review

Vitamin K: Metabolism, Genetic Influences, and Chronic Disease Outcomes

Montana Dupuy et al. Food Sci Nutr. .

Abstract

Vitamin K refers to a group of lipid-soluble vitamins that exist in two natural isoforms; phylloquinone (PK, vitamin K1) and menaquinones (MKs, vitamin K2). Phylloquinone, the primary dietary source, is found abundantly in green vegetables and plant oils. Menaquinones (MK-4 through MK-13) are synthesized by anaerobic bacteria and may be obtained through the diet from fermented foods and animal products (e.g., meats, dairy and eggs). Originally recognized for its role in blood coagulation, vitamin K is an essential cofactor for the posttranslational carboxylation of vitamin K-dependent proteins (VKDPs), which are implicated in various physiological processes including; blood coagulation, calcium homeostasis, as well as metabolic and inflammatory pathways. Therefore, vitamin K has attracted considerable research interest for its potential implications in several diseases. While promising, the specific roles of vitamin K in various health conditions, the quantity of vitamin K (both PK and MKs) required for the function of various VKDPs, and the influence of genetics on vitamin K metabolism, remain unclear. This review aims to (i) provide an overview of the structure, dietary sources, metabolism, and physiological roles of vitamin K, including those relating to; cardiovascular diseases, type 2 diabetes, respiratory conditions, musculoskeletal health and cancer; (ii) discuss the impact of genetic factors on vitamin K status and how such factors modulate the role of vitamin K in the aforementioned chronic diseases; and (iii) outline key directions for future research.

Keywords: bone health; cancer; cardiovascular disease; diabetes; vitamin K1; vitamin K2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Chain structures of vitamin K1 (phylloquinone [PK]), two vitamin K2 isoforms (menaquinone 4 [MK‐4] and menaquinone 7 [MK‐7]), and vitamin K3 (menadione). Created in BioRender. Dupuy, M. (2024) BioRender.com/m97w819.
FIGURE 2
FIGURE 2
Phylloquinone content in common dietary sources based on data from four countries: Australia (Palmer, Koch, et al. 2021), the USA (U.S. Department of Agriculture n.d.), the United Kingdom (McCance and Widdowson 2014), and Denmark (National Food Institute, Technical University of Denmark 2024).
FIGURE 3
FIGURE 3
Menaquinone‐4 content in common dietary sources based on data from five published databases, from four different regions: Australia (Palmer, Koch, et al. 2021), the USA (U.S. Department of Agriculture n.d.), the Netherlands (Schurgers and Vermeer 2000), and Denmark (National Food Institute, Technical University of Denmark ; Jensen et al. 2025). Values were left blank where no data was available.
FIGURE 4
FIGURE 4
The vitamin K cycle. Created in BioRender. Dupuy, M. (2024) BioRender.com/p68j777.

Similar articles

  • The epigenetic potential of vitamin K2 in brain health.
    Roumeliotis S, Cavallaro RA, Kontogiorgos I, Neofytou IE, Maresz K, Jeanne JF, Miraglia N, Fuso A. Roumeliotis S, et al. Epigenomics. 2025 Jul;17(10):681-690. doi: 10.1080/17501911.2025.2518916. Epub 2025 Jun 12. Epigenomics. 2025. PMID: 40506698 Free PMC article. Review.
  • Vitamin D: Production, Metabolism, and Mechanism of Action.
    Bikle DD. Bikle DD. 2025 Jun 15. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. 2025 Jun 15. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. PMID: 25905172 Free Books & Documents. Review.
  • Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.
    Haeussler K, Ismaila AS, Malmenäs M, Noorduyn SG, Green N, Compton C, Thabane L, Vogelmeier CF, Halpin DMG. Haeussler K, et al. Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x. Respir Res. 2024. PMID: 39709425 Free PMC article. Review.
  • Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.
    Xiao M, Li X, Bu F, Ma S, Yang X, Chen J, Zhao Y, Cananzi F, Luo C, Min L. Xiao M, et al. Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887. Elife. 2025. PMID: 40407808 Free PMC article.
  • Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective.
    Ramessur R, Dand N, Langan SM, Saklatvala J, Fritzsche MC, Holland S, Arents BWM, McAteer H, Proctor A, McMahon D, Greenwood M, Buyx AM, Messer T, Weiler N, Hicks A, Hecht P, Weidinger S, Ndlovu MN, Chengliang D, Hübenthal M, Egeberg A, Paternoster L, Skov L, De Jong EMGJ, Middelkamp-Hup MA, Mahil SK, Barker JN, Flohr C, Brown SJ, Smith CH. Ramessur R, et al. Br J Dermatol. 2024 Jun 20;191(1):14-23. doi: 10.1093/bjd/ljae080. Br J Dermatol. 2024. PMID: 38419411 Free PMC article. Review.

References

    1. Ahmad, K. , Choi I., and Lee Y.‐H.. 2020. “Implications of Skeletal Muscle Extracellular Matrix Remodeling in Metabolic Disorders: Diabetes Perspective.” International Journal of Molecular Sciences 21, no. 11: 3845. - PMC - PubMed
    1. Akbulut, A. C. , Pavlic A., Petsophonsakul P., et al. 2020. “Vitamin K2 Needs an RDI Separate From Vitamin K1.” Nutrients 12, no. 6: 1852. - PMC - PubMed
    1. Alfadda, A. , Masood A., Shaik S., Dekhil H., and Goran M.. 2013. “Association Between Osteocalcin, Metabolic Syndrome, and Cardiovascular Risk Factors: Role of Total and Undercarboxylated Osteocalcin in Patients With Type 2 Diabetes.” International Journal of Endocrinology 1: 197519. - PMC - PubMed
    1. Alonso, N. , Meinitzer A., Fritz‐Petrin E., Enko D., and Herrmann M.. 2023. “Role of Vitamin K in Bone and Muscle Metabolism.” Calcified Tissue International 112, no. 2: 178–196. 10.1007/s00223-022-00955-3. - DOI - PMC - PubMed
    1. Apalset, E. M. , Gjesdal C. G., Eide G. E., and Tell G. S.. 2011. “Intake of Vitamin K1 and K2 and Risk of Hip Fractures: The Hordaland Health Study.” Bone 49, no. 5: 990–995. - PubMed

LinkOut - more resources